ClinicalTrials.govpublic full text
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
b-cell lymphoma, non-hodgkin's lymphoma, lymphoma, radioimmunotherapy, bexxar, tositumomab, autologous hematopoietic stem cell transplantation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886816
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.